These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10962542)

  • 1. Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate.
    Høgh P; Oturai A; Schreiber K; Blinkenberg M; Jørgensen OS; Ryder L; Paulson OB; Sørensen PS; Knudsen GM
    Mult Scler; 2000 Aug; 6(4):226-30. PubMed ID: 10962542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The absence of a relation between apolipoprotein E genotypes and the severity of multiple sclerosis in Mexican patients].
    Corona T; Guerrero-Camacho JL; Alonso-Vilatela ME; Flores-Rivera Jde J
    Rev Neurol; 2010 Jan 1-15; 50(1):19-22. PubMed ID: 20073019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E genotype does not associate with disease severity measured by Multiple Sclerosis Severity Score.
    Guerrero AL; Laherrán E; Gutiérrez F; Martín-Polo J; Iglesias F; Alcázar C; Peralta J; Rostami P
    Acta Neurol Scand; 2008 Jan; 117(1):21-5. PubMed ID: 17883422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apo E in multiple sclerosis and optic neuritis: the apo E-epsilon4 allele is associated with progression of multiple sclerosis.
    Pinholt M; Frederiksen JL; Andersen PS; Christiansen M
    Mult Scler; 2005 Oct; 11(5):511-5. PubMed ID: 16193886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of apolipoprotein E genotypes with prognosis in multiple sclerosis.
    Tamam Y; Tasdemir N; Yalman M; Tamam B
    Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1122-30. PubMed ID: 22165672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers.
    Burwick RM; Ramsay PP; Haines JL; Hauser SL; Oksenberg JR; Pericak-Vance MA; Schmidt S; Compston A; Sawcer S; Cittadella R; Savettieri G; Quattrone A; Polman CH; Uitdehaag BM; Zwemmer JN; Hawkins CP; Ollier WE; Weatherby S; Enzinger C; Fazekas F; Schmidt H; Schmidt R; Hillert J; Masterman T; Hogh P; Niino M; Kikuchi S; Maciel P; Santos M; Rio ME; Kwiecinski H; Zakrzewska-Pniewska B; Evangelou N; Palace J; Barcellos LF
    Neurology; 2006 May; 66(9):1373-83. PubMed ID: 16682670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOE genotypes and disease severity in multiple sclerosis.
    Masterman T; Zhang Z; Hellgren D; Salter H; Anvret M; Lilius L; Lannfelt L; Hillert J
    Mult Scler; 2002 Apr; 8(2):98-103. PubMed ID: 11990879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of APOE genetic polymorphism with susceptibility to multiple sclerosis and its clinical phenotypes in Kuwaiti Arab subjects.
    Al-Shammri S; Fatania H; Al-Radwan R; Akanji AO
    Clin Chim Acta; 2005 Jan; 351(1-2):203-7. PubMed ID: 15563891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E genotype does not influence the progression of multiple sclerosis.
    Savettieri G; Andreoli V; Bonavita S; Cittadella R; Caltagirone C; Fazio MC; Girlanda P; Le Pira F; Liguori M; Logroscino G; Lugaresi A; Nocentini U; Reggio A; Salemi G; Serra P; Tedeschi G; Toma L; Trojano M; Valentino P; Quattrone A
    J Neurol; 2003 Sep; 250(9):1094-8. PubMed ID: 14504972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis.
    Fazekas F; Strasser-Fuchs S; Kollegger H; Berger T; Kristoferitsch W; Schmidt H; Enzinger C; Schiefermeier M; Schwarz C; Kornek B; Reindl M; Huber K; Grass R; Wimmer G; Vass K; Pfeiffer KH; Hartung HP; Schmidt R
    Neurology; 2001 Sep; 57(5):853-7. PubMed ID: 11552016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary observations on APOE epsilon4 allele and progression of disability in multiple sclerosis.
    Chapman J; Sylantiev C; Nisipeanu P; Korczyn AD
    Arch Neurol; 1999 Dec; 56(12):1484-7. PubMed ID: 10593303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of apolipoprotein E and myeloperoxidase genotypes to clinical course of familial and sporadic multiple sclerosis.
    Zakrzewska-Pniewska B; Styczynska M; Podlecka A; Samocka R; Peplonska B; Barcikowska M; Kwiecinski H
    Mult Scler; 2004 Jun; 10(3):266-71. PubMed ID: 15222689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No major association of ApoE genotype with disease characteristics and MRI findings in multiple sclerosis.
    Zwemmer JN; van Veen T; van Winsen L; van Kamp GJ; Barkhof F; Polman CH; Uitdehaag BM
    Mult Scler; 2004 Jun; 10(3):272-7. PubMed ID: 15222690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E polymorphism interacts with cigarette smoking in progression of multiple sclerosis.
    Sena A; Couderc R; Ferret-Sena V; Pedrosa R; Andrade ML; Araujo C; Roque R; Cascais MJ; Morais MG
    Eur J Neurol; 2009 Jul; 16(7):832-7. PubMed ID: 19473356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosis.
    Weatherby SJ; Mann CL; Davies MB; Carthy D; Fryer AA; Boggild MD; Young C; Strange RC; Ollier W; Hawkins CP
    Mult Scler; 2000 Feb; 6(1):32-6. PubMed ID: 10694843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Apolipoprotein E polymorphism as a predictor of progression of multiple sclerosis].
    Guerrero AL; Bueno V; Hernández MT; Martín-Serradilla JI; Carrasco E; Cuadrado I
    Neurologia; 2003 Apr; 18(3):146-8. PubMed ID: 12677480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E polymorphisms status in Iranian patients with multiple sclerosis.
    Rafiei M; Zarif Yeganeh M; Sheikholeslami S; Gozalpour E; Ghaffarpour M; Hedayati M
    J Neurol Sci; 2012 Sep; 320(1-2):22-5. PubMed ID: 22698480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E gene polymorphism and the risk of cervical myelopathy in patients with chronic spinal cord compression.
    Setzer M; Hermann E; Seifert V; Marquardt G
    Spine (Phila Pa 1976); 2008 Mar; 33(5):497-502. PubMed ID: 18317192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE genotype is a major predictor of long-term progression of disability in MS.
    Chapman J; Vinokurov S; Achiron A; Karussis DM; Mitosek-Szewczyk K; Birnbaum M; Michaelson DM; Korczyn AD
    Neurology; 2001 Feb; 56(3):312-6. PubMed ID: 11171894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the APOE epsilon4 allele with disease activity in multiple sclerosis.
    Evangelou N; Jackson M; Beeson D; Palace J
    J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):203-5. PubMed ID: 10406990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.